Concepedia

Author

G. Fleischhack

University of Bonn

Also Known As

Fleischhack G., G Fleischhack, G. Fleischhack, Gruhn, B., M. Benesch

40

Publications

559

Citations

11

H-Index

33

Concepts

All Affiliations

University of BonnUniversity Hospital BonnSt Anna Children's Hospital
GF

About

G. Fleischhack is an author at University of Bonn specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

257

2

Health Sciences

3

3

99

3

Pathology

2

2

52

4

Immunology

1

1

33

5

Neurology

1

1

15

G. Fleischhack

×

9

Publications

458

Citations

9

H-Index

YearCitations

Carboxypeptidase G2 rescue in patients with methotrexate intoxication and renal failure

Sylvia Buchen, Doris NGampolo, RG Melton,

British Journal of Cancer

2005

146

Compassionate use of bevacizumab (Avastin®) in children and young adults with refractory or recurrent solid tumors

Martin Benesch, M. Windelberg, Werner Sauseng,

Annals of Oncology

2007

90

Meropenem versus ceftazidime as empirical monotherapy in febrile neutropenia of paediatric patients with cancer

G. Fleischhack

Journal of Antimicrobial Chemotherapy

2001

65

Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients

G. Fleischhack, M. Schmidt-Niemann, Beate Wulff,

Supportive Care in Cancer

2001

35

Procalcitonin – a sensitive inflammation marker of febrile episodes in neutropenic children with cancer

G. Fleischhack, Dubravka Cipic, J. Juettner,

Intensive Care Medicine

2000

33

Cerebral Venous Sinus Thrombosis in Children with Acute Lymphoblastic Leukemia carrying the MTHFR TT677 Genotype and Further Prothrombotic Risk Factors

C. Wermes, G. Fleischhack, R. Junker,

Klinische Pädiatrie

1999

31

Pancreatic toxicity after liposomal amphotericin B

A. Stuecklin‐Utsch, Carola Hasan, U. Bode,

Mycoses

2002

24

INTRACRANIAL MANIFESTATION OF OSTEOSARCOMA

Simone Hettmer, G. Fleischhack, Carola Hasan,

Pediatric Hematology and Oncology

2002

19

Results of a phase II trial of h-R3 monoclonal antibody (nimotuzumab) in the treatment of resistant or relapsed high-grade gliomas in children and adolescents

U. Bode, Sylvia Buchen, T. Reinhard,

Journal of Clinical Oncology

2006

15

Page 1